Regeneca Reaches Recall: Health And Wellness Industry News Roundup
This article was originally published in The Rose Sheet
Executive Summary
Closed VivaCeuticals business recalls products; Nutrition 21 extends Glanbia distribution agreement; and more news in brief.
You may also be interested in...
DMAA Supplement Direct Seller Ceases Operations Under Consent Decree
DoJ filed enters consent decree with VivaCeuticals that forces the California firm to cease marketing its RegeneSlim appetite control product, which was found to contain the stimulant DMAA, and because it violated GMP regulations.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.